NewsRx

Search our medical news database

Breast Cancer (Animal Studies)

Combined Therapeutic Agents Inhibit the Growth of Breast Cancers in Mice

Published in Women's Health Weekly, November 29th, 1999

Antiestrogen, EM-652.HCI, is most effective when teamed with other weapons against breast cancer

S. Couillard, of the University of Quebec, and associates compared EM-652.HCL used alone or in conjunction with radiation therapy and Caelyx. Their study, entitled, "Effects of the Antiestrogen Em-652.hcl in Combination with Radiotherapy and/or Caelyx on ZR-75-1 Human Breast Tumor Growth in Nude Mice," was presented at the 6th International Congress on Hormones and Cancer, held September 5-9, 1999, in Jerusalem, Israel.

"The present data indicate that combined treatment using EM-652.HCI with chemotherapeutic agents and/or radiotherapy can produce a...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook